NCT03318315: A reported trial by National Institute of Allergy and Infectious Diseases (NIAID)
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT03318315 |
|---|---|
| Title | A Phase II Study in Healthy Adults (19-64 Years of Age) to Assess the Safety, Reactogenicity and Immunogenicity of Sequential or Simultaneous Intramuscular Administration of an AS03-adjuvanted A/H7N9 Inactivated Influenza Vaccine With Seasonal Influenza Vaccine |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Feb. 20, 2018 |
| Completion date | July 25, 2019 |
| Required reporting date | July 24, 2020, midnight |
| Actual reporting date | July 16, 2020 |
| Date last checked at ClinicalTrials.gov | March 28, 2025 |
| Days late | None |